Insurance¿Í ¾à»ç¹ý - Key Points 2010.02.20 | Public relations: Á¶Á÷°ú °øÁß(Public)°úÀÇ °ü°è¸¦ Çü¼ºÇÏ´Â °ÍÀ» PRÀ̶ó°í ÇÏ¸ç ½±°Ô´Â È«º¸¸¦ »ý°¢ÇÏ¸é µÈ´Ù.
¿¹µé:
1. Corporations use marketing public relations (MPR) to convey information about the products they manufacture or services th... | | Biotechnology - Key Points 2010.02.20 | 1. Omalizumab (OMZ) is a recombinant, humanized monoclonal anti-IgE antibody. It inhibits the immune system¡¯s response to allergens in a dose-dependent manner, by binding to free IgE and resulting in ... | | Microbiology - Key Points 2010.02.20 | 1. Methicillin-sensitive staphylococciÀÇ DOC´Â? Cefazolin
2. General population¿¡¼ methicillin-resistant S. aureusÀÇ carrigae rateÀº? 25-50%
3. Methicillin-resistant S. aureusÀÇ risk factor°¡ ¾Æ´Ñ °ÍÀº?
a. in... | | |
|
24ÁÖ: Gout and Others ½Ç½Ã°£ °ÀÇ Recording 2009.12.14 | 2009/5/9 ½Ç½Ã°£ °ÀÇ ³ìȺÐÀÔ´Ï´Ù. °ÀÇ ¹üÀ§´Â APhA Review Chapter 22 Gout°ú °ÀÇ¿¡¼ ´Ù·çÁö ¾ÊÀº ´Ù¸¥ ÁúȯµéÀÔ´Ï´Ù.
¿©±â¸¦ Ŭ¸¯ÇÏ½Ã¸é °ÀǸ¦ ½ÃûÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
À§ÀÇ pdf ÆÄÀÏÀ» ´Ù¿î·Îµå¹Þ¾Æ¼ ÀμâÇϽŠ´ÙÀ½, Çʱ⿡ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù. | | 23ÁÖ: Dementia ½Ç½Ã°£ °ÀÇ Recording 2009.12.14 | 2009/5/7 ½Ç½Ã°£ °ÀÇ ³ìȺÐÀÔ´Ï´Ù. °ÀÇ ¹üÀ§´Â APhA Review Chapter 34 Geriatrics and Gerontology (Alzheimer's Disease)ÀÔ´Ï´Ù.
¿©±â¸¦ Ŭ¸¯ÇÏ½Ã¸é °ÀǸ¦ ½ÃûÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
À§ÀÇ pdf ÆÄÀÏÀ» ´Ù¿î·Îµå¹Þ¾Æ¼ ÀμâÇϽŠ´ÙÀ½, Çʱ⿡ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù. | | 22ÁÖ: Top 200 Drugs part 12 ½Ç½Ã°£ °ÀÇ Recording 2009.12.14 | 2009/5/4 ½Ç½Ã°£ °ÀÇ ³ìȺÐÀÔ´Ï´Ù. °ÀÇ ¹üÀ§´Â Top 200 Drugs part 12ÀÔ´Ï´Ù.
¿©±â¸¦ Ŭ¸¯ÇÏ½Ã¸é °ÀǸ¦ ½ÃûÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
À§ÀÇ pdf ÆÄÀÏÀ» ´Ù¿î·Îµå¹Þ¾Æ¼ ÀμâÇϽŠ´ÙÀ½, Çʱ⿡ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù. | | |